DOI: 10.1055/s-00023610

Drug Research



Kaku K, Watada H, Iwamoto Y. et al
Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: A combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study.

Cardiovasc Diabetol 2014;
13: 65

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: